NYSE:GTS

Stock Analysis Report

Executive Summary

Triple-S Management Corporation, through its subsidiaries, provides a portfolio of managed care and related products in the commercial, Medicare Advantage, and Medicaid markets.

Snowflake

Fundamentals

Good value with adequate balance sheet.


Similar Companies

Share Price & News

How has Triple-S Management's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-3.7%

GTS

0.6%

US Healthcare

1.0%

US Market


1 Year Return

-17.5%

GTS

-9.4%

US Healthcare

6.7%

US Market

Return vs Industry: GTS underperformed the US Healthcare industry which returned -9.4% over the past year.

Return vs Market: GTS underperformed the US Market which returned 6.7% over the past year.


Share holder returns

GTSIndustryMarket
7 Day-3.7%0.6%1.0%
30 Day-17.9%-3.3%-1.8%
90 Day-40.6%-8.9%-1.8%
1 Year-17.5%-17.5%-8.0%-9.4%9.1%6.7%
3 Year-32.0%-32.0%30.0%24.8%46.1%36.6%
5 Year-27.0%-27.0%60.1%50.5%66.9%48.6%

Price Volatility Vs. Market

How volatile is Triple-S Management's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Triple-S Management undervalued based on future cash flows and its price relative to the stock market?

8.96x

Price to Earnings (PE) ratio


Intrinsic Value Based on Future Cash Flows

Undervalued: Insufficient data to calculate GTS's fair value to establish if it is undervalued.

Significantly Undervalued: Insufficient data to calculate GTS's fair value to establish if it is undervalued.


Price Based on Earnings

PE vs Industry: GTS is good value based on its PE Ratio (9x) compared to the Healthcare industry average (19.9x).

PE vs Market: GTS is good value based on its PE Ratio (9x) compared to the US market (17.5x).


Price Based on Expected Growth

Low PEG Ratio: GTS is good value based on its PEG Ratio (0.7x)


Price Based on Value of Assets

PB vs Industry: GTS is good value based on its PB Ratio (0.4x) compared to the US Healthcare industry average (2.4x).


Next Steps

Future Growth

How is Triple-S Management expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

12.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Earnings vs Savings Rate: GTS's forecast earnings growth (12.9% per year) is above the savings rate (2.7%).

Earnings vs Market: GTS's earnings (12.9% per year) are forecast to grow slower than the US market (14.5% per year).

High Growth Earnings: GTS's earnings are forecast to grow, but not significantly.

Revenue vs Market: GTS's revenue (8.4% per year) is forecast to grow faster than the US market (7.3% per year).

High Growth Revenue: GTS's revenue (8.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Estimates


Future Return on Equity

High Future ROE: Insufficient data to determine if GTS's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Triple-S Management performed over the past 5 years?

-35.9%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: GTS's earnings have declined by -35.9% per year over the past 5 years.

Accelerating Growth: GTS's earnings growth over the past year (229.9%) exceeds its 5-year average (-35.9% per year).

Earnings vs Industry: GTS earnings growth over the past year (229.9%) exceeded the Healthcare industry 5.3%.


Return on Equity

High ROE: GTS's Return on Equity (4%) is considered low.


Return on Assets

ROA vs Industry: GTS's Return on Assets is below or equal to the Healthcare industry average last year.


Return on Capital Employed

ROCE Improving: GTS has significantly improved its Return on Capital Employed over the past 3 years.


Next Steps

Financial Health

How is Triple-S Management's financial position?


Financial Position Analysis

Short Term Liabilities: GTS's short term assets ($775.8M) do not cover its short term liabilities ($1.5B)

Long Term Liabilities: GTS's short term assets (775.8M) exceeds its long term liabilities (439.7M)


Debt to Equity History and Analysis

Debt Level: GTS's debt to equity ratio (3%) is considered satisfactory

Reducing Debt: GTS's debt to equity ratio has reduced from 10.3% to 3% over the past 5 years.

Debt Coverage: GTS's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: GTS's interest payments on its debt are well covered by EBIT (10.3x coverage).


Balance Sheet

Inventory Level: GTS has a low level of unsold assets or inventory.

Debt Coverage by Assets: GTS's debt is covered by short term assets (assets are 28.428850x debt).


Next Steps

Dividend

What is Triple-S Management's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.5%markettop25%3.8%industryaverage1.3%forecastin3Yearsn/a

Current dividend yield vs market & industry


Dividend Yield and Payments Analysis

Notable Dividend: Unable to evaluate GTS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate GTS's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if GTS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if GTS's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of GTS's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of Triple-S Management's salary, the management and board of directors tenure and is there insider trading?

3.8yrs

Average management tenure


CEO

Roberto García-Rodríguez (55yo)

3.8yrs

Tenure

US$3,249,141

Compensation

Mr. Roberto Garcia-Rodriguez, Esq., has been the Chief Executive Officer and President of Triple-S Management Corporation since January 1, 2016. Mr. Garcia-Rodriguez served as the Chief Operating Officer o ...


CEO Compensation Analysis

Compensation vs. Market: Roberto's total compensation ($USD3.25M) is above average for companies of similar size in the US market ($USD1.85M).

Compensation vs Earnings: Roberto's compensation has been consistent with company performance over the past year.


Management Age and Tenure

3.8yrs

Average Tenure

55yo

Average Age

Experienced Management: GTS's management team is considered experienced (3.8 years average tenure).


Board Age and Tenure

6.5yrs

Average Tenure

66yo

Average Age

Experienced Board: GTS's board of directors are considered experienced (6.5 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

BuyUS$49,54021 Dec 18
Luis Clavell Rodríguez
EntityIndividual
Role
Chairman of the Board
Chairman of the Board & Chief medical officer
Shares3,234.26
Max PriceUS$15.32
BuyUS$46,60419 Dec 18
Roberto García-Rodríguez
EntityIndividual
Role
Chief Executive Officer
President
Shares3,021.93
Max PriceUS$15.42
BuyUS$28,15619 Dec 18
Roberto García-Rodríguez
EntityIndividual
Role
Chief Executive Officer
President
Shares1,900.4
Max PriceUS$15.40

Ownership Breakdown


Management Team

  • Arturo Carrión-Crespo (61yo)

    President of Triple-S Vida Inc

    • Tenure: 21.8yrs
    • Compensation: US$941.72k
  • Juan Román-Jiménez (54yo)

    Executive VP & CFO

    • Tenure: 3.8yrs
    • Compensation: US$1.49m
  • Roberto García-Rodríguez (55yo)

    President

    • Tenure: 3.8yrs
    • Compensation: US$3.25m
  • Luis Clavell Rodríguez (68yo)

    Chairman of the Board & Chief medical officer

    • Tenure: 11.4yrs
    • Compensation: US$319.99k
  • Garrett Edson

    Investor Relations Contact

    • Tenure: 0yrs
  • Francisco Martorell-Basanta (56yo)

    Vice President of Corporate Development

    • Tenure: 11.5yrs
  • Carlos Rodriguez Ramos (40yo)

    Chief Legal Counsel & Secretary

    • Tenure: 3.8yrs
  • Madeline Hernández-Urquiza (55yo)

    Chief Operating Officer & Executive Vice President

    • Tenure: 2.2yrs
    • Compensation: US$1.65m
  • Jose Novoa-Loyola (54yo)

    Chief Medical Officer

    • Tenure: 4.3yrs
    • Compensation: US$990.88k
  • Ivelisse Fernández-Cruz (48yo)

    Chief Marketing & Communications Officer

    • Tenure: 1.8yrs

Board Members

  • Jorge Fuentes-Benejam (70yo)

    Independent Director

    • Tenure: 11.5yrs
    • Compensation: US$193.33k
  • Gail Marcus (62yo)

    Independent Director

    • Tenure: 2.3yrs
    • Compensation: US$190.00k
  • David Chafey (65yo)

    Independent Director

    • Tenure: 6.5yrs
    • Compensation: US$201.33k
  • Manuel Figueroa-Collazo (64yo)

    Independent Director

    • Tenure: 15.8yrs
    • Compensation: US$202.33k
  • Joe Frick (66yo)

    Independent Director

    • Tenure: 6.5yrs
    • Compensation: US$202.00k
  • Roberto García-Rodríguez (55yo)

    President

    • Tenure: 3.8yrs
    • Compensation: US$3.25m
  • Luis Clavell Rodríguez (68yo)

    Chairman of the Board & Chief medical officer

    • Tenure: 11.4yrs
    • Compensation: US$319.99k
  • Cari Dominguez (67yo)

    Vice Chairman & Lead Independent Director

    • Tenure: 0yrs
    • Compensation: US$205.33k
  • Roberto María-Ros (67yo)

    Independent Director

    • Tenure: 4.8yrs
    • Compensation: US$202.00k

Company Information

Triple-S Management Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Triple-S Management Corporation
  • Ticker: GTS
  • Exchange: NYSE
  • Founded: 1959
  • Industry: Managed Health Care
  • Sector: Healthcare
  • Market Cap: US$335.284m
  • Shares outstanding: 24.07m
  • Website: https://management.grupotriples.com

Number of Employees


Location

  • Triple-S Management Corporation
  • 1441 F.D. Roosevelt Avenue
  • San Juan
  • Puerto Rico
  • 936
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
GTSNYSE (New York Stock Exchange)YesClass B Common StockUSUSDDec 2007
4T3ADB (Deutsche Boerse AG)YesClass B Common StockDEEURDec 2007

Biography

Triple-S Management Corporation, through its subsidiaries, provides a portfolio of managed care and related products in the commercial, Medicare Advantage, and Medicaid markets. It operates through three s ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/14 02:11
End of Day Share Price2019/10/11 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

© 2018 SIMPLY WALL STREET PTY LTD, COMMUNITY DESIGN 2845206, US DESIGN PATENT #29/544/281, EUROPEAN DESIGN REGISTRATION #2845206, STANDARD & POOR’S FINANCIAL SERVICES LLC. ALL RIGHTS RESERVED.

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Copyright © 2018, Standard & Poor’s Financial Services LLC. Reproduction of S&P Capital IQ in any form is prohibited except with the prior written permission of S&P. S&P does not guarantee the accuracy, adequacy, completeness or availability of any information and is not responsible for any errors or omissions, regardless of the cause or for the results obtained from the use of such information. S&P DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall S&P be liable for any direct, indirect, special or consequential damages, costs, expenses, legal fees, or losses (including lost income or lost profit and opportunity costs) in connection with subscriber’s or others’ use of S&P Capital IQ. (2018)